Contraceptive vaginal rings: A review

Contraception

Volumn 82, Issue 5, 2010, Pages 418-427

  Brache, Vivian ^a   Faundes, Anibal ^b  

^a PROFAMILIA   (Dominican Republic)

^b Center for Mother and Child Research of Campinas   (Brazil)

Author keywords

Contraceptive vaginal rings; Hormonal contraception; Long acting contraception

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; ELCOMETRINE; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; LEVONORGESTREL; LIVER PROTEIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

BIOAVAILABILITY; CLINICAL EFFECTIVENESS; COITUS; HEADACHE; HEMOSTASIS; HORMONAL CONTRACEPTION; HUMAN; LEUKORRHEA; NAUSEA; PREGNANCY RATE; REVIEW; UTERINE CERVIX CAP; VAGINA DISCHARGE; VAGINA EPITHELIUM; VAGINA RING; VAGINITIS;

EID: 77957753871     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.04.012     Document Type: Review

References (90)

1. Cleland J., Bernstein S., Ezeh A., Faundes A., Glasier A., and Innis J. Family planning; the unfinished agenda Lancet 368 2006 1810 1827
2. Mishell D.R., and Lumkin M.E. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings Fertil Steril 21 1970 99 103
3. Dzuik P.J., and Cook B. Passage of steroids through silicone rubber Endocrinology 78 1966 208
4. Greenblatt R.B. The physiologic effectiveness of progesterone vaginal suppositories J Clin Endocrinol Metab 14 1954 1564 1567
5. Widholm O., and Vartiainen E. The absorption of conjugated estrogens and sodium estrone sulfate from the vagina Ann Chir Gynecol Fenn 63 1974 186 190
6. Alexander N.J., Baker E., Kaptein M., Karck U., Miller L., and Zampaglione E. Why consider vaginal drug administration? Fertil Steril 82 2004 1 12
7. Brache V., Alvarez-Sanchez F., and Faundes A. Progestin-only contraceptive rings Steroids 65 2000 687 696
8. Landgren B.M., Johannisson E., Masironi B., and Diczfalusy E. Pharmacokinetics and pharmacodynamic investigation with vaginal devices releasing levonorgestrel at a constant near zero order rate Contraception 26 1982 567 585
9. Jackson R., and Newton J.R. The in vivo release characteristics of a multi-compartment vaginal ring releasing 3-keto-desogetrel Contraception 40 1989 615 621
10. Timmer C.J., and Moulders T.M. Pharmacokinetics of etonorgestrel and ethinyl estradiol released from a combined contraceptive vaginal ring Clin Pharmacokinet 39 2000 233 242
11. Rosenberg M., and Waugh M.S. Causes and consequences of oral contraceptive noncompliance Am J Obstet Gynecol 180 1999 276 279
12. Faundes A., Hardy E.E., and Reyes Q. Acceptability of the contraceptive vaginal ring by rural and urban population in two Latin American countries Contraception 24 1981 393 414
13. Hardy E.E., Reyes Q., and Gómez F. User's perception of the contraceptive vaginal ring: a field study in Brazil and the Dominican Republic Stud Fam Plann 14 1983 284 290
14. Roumen F.J., and Dieben T.O. Clinical acceptability of an ethylene-vinyl-acetate non-medicated vaginal ring Contraception 59 1999 59 62
15. Weisberg E., Fraser I.S., and Mishell D.R. Jr The acceptability of a combined estrogen/progestogen contraceptive vaginal ring Contraception 51 1995 39 44
16. Novak A., de la Loge C., and Abetz L. The combined contraceptive vaginal ring, NuvaRing®: an international study of user acceptability Contraception 67 2003 187 194
17. Ahrendt H.J., Nisand I., Bastianelli C., Gómez A.M., Gemzell-Danielsson K., and Urdl W. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 3 μg of ethinyl estradiol and 3 mg of drospirenone Contraception 74 2006 451 457 (Pubitemid 46043314)
18. Mishell D.R., Moore D.E., and Roy S. Clinical performance and endocrine profile with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel Am J Obstet Gynecol 130 1978 55 62
19. Toivonen J., Lahteenmaki P., and Luukkainen T. Pituitary and gonadal function during the use of norgestrel-estradiol vaginal rings Contraception 18 1978 201 211
20. Jackanicz T.M. Levonorgestrel and estradiol release from an improved contraceptive vaginal ring Contraception 24 1981 323 339
21. Sivin I., Mishell D. Jr, and Victor A. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings: I. Use effectiveness. An international comparative trial Contraception 24 1981 341 358 (Pubitemid 12239507)
22. Sivin I., Mishell D. Jr, and Victor A. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings: II. Subjective and objective measures of effects. An international comparative trial Contraception 24 1981 359 376 (Pubitemid 12239508)
23. Sivin I., Mishell D. Jr, and Victor A. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings: III. Menstrual patterns. An international comparative trial Contraception 24 1981 377 392 (Pubitemid 12239509)
24. Ahren T., Lithell H., and Victor A. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring: II. Serum lipoproteins and apolipoproteins Contraception. 24 1981 471 478
25. Robertson D.N., Alvarez F., and Sivin I. Lipoprotein patterns in women in Santo Domingo using a levonorgestrel/estradiol contraceptive ring Contraception 24 1981 469 480
26. Roy S., Krauss R.M., and Mishell D.R. Jr The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiol Contraception 24 1981 429 449
27. Adams M.R., Clarkson T.B., and Koritnik D.R. Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques Fertil Steril 47 1987 1010 1018
28. Ballagh S., Mishell D., and Jackanicz T. Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol Contraception 50 1994 535 549
29. Ballagh S.A., Mishell D.R. Jr, and Lacarra M. A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol Contraception 50 1994 517 533
30. Weisberg E., Fraser I.S., and Lacarra M. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring Contraception 56 1997 233 239
31. Weisberg E., Fraser I.S., and Mishell D.R. Jr A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol Contraception 59 1999 305 310
32. Weisberg E., Fraser I.S., and Lacarra M. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring Contraception 59 1999 311 318
33. Alvarez-Sanchez F., Brache V., and Jackanicz T. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles Contraception 46 1992 387 398
34. Laurikka-Routti M., Haukkamaa M., and Heikinheimo O. A contraceptive vaginal ring releasing EE and the progestin ST1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry Contraception 42 1990 111 120
35. Sivin I., Mishell D.R., and Alvarez F. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial Contraception 71 2005 122 129
36. Fraser I.S., Weisberg E., and Brache V. Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone® progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen Contraception 72 2005 40 45
37. Weisberg E., Brache V., and Alvarez F. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone® progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen Contraception 72 2005 46 52 (Pubitemid 40827118)
38. Fraser I.S., Lacarra M., and Mishell D.R. Jr Vaginal epithelial surface appearances in women using vaginal rings for contraception Contraception 61 2000 131 138
39. Croxatto H.B., Brache V., and Massai R. Feasibility study of Nestorone®-ethinylestradiol vaginal contraceptive ring for emergency contraception Contraception 73 2006 46 52
40. Apter D., Cacciatore B., and Stenman U.H. Clinical performance and endocrine profiles of contraceptive vaginal rings releasing 3-keto-desogestrel and ethinylestradiol Contraception 42 1990 285 295
41. Olsson S.E., and Odlind V. Contraception with a vaginal ring releasing 3-keto-desogestrel and ethinylestradiol Contraception 42 1990 563 572
42. Timmer C.J., Apter D., and Voortman G. Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings Contraception 42 1990 629 642
43. Kirkman R.J., Bounds W., and Colliver D. Practical experience in the UK with an oestrogen/progestogen contraceptive vaginal ring Br J Fam Plann 18 1992 12 15
44. Schindeler A.E. The 3-keto-desogestrel/ethinylestradiol ring: a new parenteral form of hormonal contraception Eur J Obstet Gynecol Reprod Biol 49 1993 13 14
45. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research Development and Research Training in Human Reproduction. Microdose intravaginal levonorgestrel contraception: a multicenter clinical trial: I. Contraceptive efficacy and side effects Contraception 41 1990 105 124
46. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research Development and Research Training in Human Reproduction. Microdose intravaginal levonorgestrel contraception: a multicenter clinical trial: II. Expulsions and removals Contraception 41 1990 125 141
47. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research Development and Research Training in Human Reproduction. Microdose intravaginal levonorgestrel contraception: a multicenter clinical trial: III. The relationship between pregnancy rate and body weight Contraception 41 1990 143 150
48. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research Development and Research Training in Human Reproduction. Microdose intravaginal levonorgestrel contraception: a multicenter clinical trial: IV. Bleeding patterns Contraception 41 1990 151 167
49. Bounds W., Szarewski A., and Lowe D. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring Eur J Obstet Gynecol Reprod Biol 48 1993 123 125
50. Brache V., Mishell D.R., and Lahteenmaki P. Ovarian function during use of vaginal rings delivering three different doses of NES Contraception 63 2001 257 261
51. Massai R., Diaz S., and Jackanicz T. Vaginal rings for contraception in lactating women Steroids 65 2000 703 707
52. Buckman M.T., Johnson J., Ellis H., Srivastava L., and Peake G.T. Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate Metabolism 29 1980 803 805
53. Goebelsmann U., Maschak C.A., and Mishell D.R. Comparison of hepatic impact of oral and vaginal administration of ethynil estradiol Am J Obstet Gynecol 151 1985 868 877
54. Tougerman D.E., Slater C.C., and Stanczyk S.Z. Endocrine and clinical effects of micronized estradiol administered vaginally or orally Fertil Steril 75 2001 200 202
55. Sitruk-Ware R., Plu-Bureau G., and Menard J. Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study J Clin Endocrinol Metab 92 2007 2074 2079
56. Rad M., Kluft C., Menard J., Burggraaf J., Kam M.L., and Meijer P. Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables Am J Obstet Gynecol 195 2006 72 77
57. Sitruk-Ware R.L., Menard J., Rad M., Burggraaf J., Kam M.L., and Tokay B.A. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen Contraception 75 2007 430 437
58. Fleischer K., van Vliet H.A., Rosendaal F.R., Rosing J., Tchaikovski S., and Helmerhorst F.M. Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross over study Thromb Res 123 2009 429 435
59. Jensen J.T., Burke A.E., Barnhart K.T., Tillotson C., Messerle-Forbes M., and Peters D. Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis Contraception 78 2004 451 458
60. Diaz S., Jackanicz T.M., and Herreros C. Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of progesterone-releasing vaginal rings Contraception 32 1985 603 622
61. Massai R., Miranda P., and Valdez P. Preregistration study on the safety and contraceptive efficacy of the progesterone-releasing vaginal ring in Chilean nursing women Contraception 60 1999 9 14
62. Diaz S., Zepeda A., and Maturana X. Fertility regulation in nursing women: IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and copper T 380A intrauterine devices Contraception 56 1997 223 232
63. Sivin I., Diaz S., and Croxatto H. Contraception for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380 IUD Contraception 55 1997 225 232
64. Massai R., Quinteros E., and Reyes M.V. Extended use of a progesterone-releasing vaginal ring in nursing women: a Phase II clinical trial Contraception 72 2005 352 357
65. Mulders T.M., and Dieben T.O. Use of the novel combined vaginal ring NuvaRing for ovulation inhibition Fertil Steril 75 2001 865 870
66. Duijkers I.J.M., Klipping C., Verhoeven C.H.J., and Dieben T.O.M. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: randomized study Hum Reprod 19 2004 2668 2673
67. Heuvel M.W., Bragt A.J., Alnabawy A.K., and Kaptein M.C. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive Contraception 72 2005 168 174
68. Roumen F.J., Apter D., and Mulders T.M. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl estradiol Hum Reprod 16 2001 469 475
69. Dieben T.O., Roumen F.J., and Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring Obstet Gynecol 100 2002 585 593
70. Oddsson K., Leifels-Fisher B., Melo N.R., Wiel-Masson D., Benedetto C., and Verhoeven C.H.J. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial Contraception 71 2005 176 182
71. Roumen F.J. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials Contraception 75 2007 420 429
72. Roumen F.J.M.E. Review of the combined contraceptive vaginal ring, (NuvaRing®) Ther Clin Risk Manag 4 2008 441 451
73. Lopez L.M., Grimes D.A., Gallo M.F., and Schulz K.F. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Systematic Reviews In: The Cochrane Library 2010 10.1002/14651858.CD003552.pub1 Issue 1, Art. No. CD003552
74. Schafer J.E., Osborne L.M., Davis A.R., and Westhoff C. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus oral contraceptive Contraception 73 2006 488 492
75. Creinin M.D., Meyn L.A., and Borgatta L. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial Obstet Gynecol 111 2008 267 277
76. Veres S., Miller L., and Burington B. A comparison between the vaginal ring and oral contraceptives Obstet Gynecol 104 2004 555 563
77. Davies G.C., Fenf L.X., and Newton J.R. The effects of a combined contraceptive vaginal ring releasing ethinylestradiol and 3-ketodesogestrel on vaginal flora Contraception 45 1992 511 518
78. O'Connell K.J., Osbborne L.M., and Westhoff C. Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive Contraception 72 2005 323 327
79. Milsom I., Lete I., Bjertnaes A., Rokstad K., Lindh I., and Gruber C.J. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 μg ethinyl estradiol and 3 mg drospirenone Hum Reprod 21 2006 2304 2311
80. Tuppurainen M., Klimscheffskij R., Venhola M., and Dieben T.O. The combined contraceptive vaginal ring (NuvaRing®) and lipid metabolism: a comparative study Contraception 69 2004 389 394
81. Duijkers I., Killick S., Bigrigg A., and Dieben T.O. A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal thyroid function Eur J Contracept Reprod Health Care 9 2004 131 140
82. Massai R., Mäkäräinen L., Kuukankorpi A., Klipping C., Duijkers L., and Dieben T. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women Hum Reprod 20 2005 2764 2768
83. Bulten J., Grefte J., Siebers B., and Dieben T. The combined contraceptive vaginal ring (NuvaRing®) and endometrial histology Contraception 72 2005 362 365 (Pubitemid 41503134)
84. Oddsson K., Leifels-Fisher B., Wiel-Masson D., de Melo N.R., Benedetto C., and Verhoeven C.H.J. Superior cycle control with contraceptive vaginal ring compared with an oral contraception containing 30 μg ethinylestradiol and 150 μg levonorgestrel: a randomization trial Hum Reprod 20 2005 557 562
85. Bjarnadottir R.I., Tuppurainen M., and Killick S.R. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ ethinyl estradiol Am J Obstet Gynecol 186 2002 389 395
86. Westhoff C., Osborne L.M., Schafer J.E., and Morroni C. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive Obstet Gynecol 106 2005 89 96
87. Miller L., Verhoeven C.H., and Hout J. Extended regimens of the contraceptive vaginal ring: a randomized trial Obstet Gynecol 106 2005 473 482
88. Barreiros F.A., Guazzelli C.A., de Araújo F.F., and Barbosa R. Bleeding patterns of women using extended regimens of the contraceptive vaginal ring Contraception 75 2007 204 208
89. Sulak P.J., Smith V., Coffee A., Witt I., Kuehl A.L., and Kuehl T.J. Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring. A randomized controlled trial Obstet Gynecol 112 2008 563 571
90. Guazzelli C.A., Barreiros F.A., Barbosa R., de Araújo F.F., and Moron A.F. Extended regimens of the vaginal contraceptive ring: cycle control Contraception 80 2009 430 435